As MME was significantly downregulated in tumor tissues and is involved in the PI3K/Akt pathway, we suggest that MME may act as a tumor suppressor in breast cancer by regulating the PI3K/Akt signaling pathway, especially its downstream FoxO signaling pathway. This evidence concerns the gene AKT1 and neoplasm.